Jonathan J. Hogan

1.4k total citations
31 papers, 556 citations indexed

About

Jonathan J. Hogan is a scholar working on Nephrology, Molecular Biology and Hematology. According to data from OpenAlex, Jonathan J. Hogan has authored 31 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 10 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Jonathan J. Hogan's work include Renal Diseases and Glomerulopathies (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jonathan J. Hogan is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Jonathan J. Hogan collaborates with scholars based in United States, France and Netherlands. Jonathan J. Hogan's co-authors include Jai Radhakrishnan, Jordana B. Cohen, Glen S. Markowitz, Brendan M. Weiss, Raymond R. Townsend, Abdallah Sassine Geara, Nelson Leung, Mariam P. Alexander, Matthew B. Palmer and Audrey Uffing and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Jonathan J. Hogan

28 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan J. Hogan United States 14 251 200 135 84 79 31 556
Shikha Wadhwani United States 6 262 1.0× 79 0.4× 101 0.7× 29 0.3× 55 0.7× 13 522
Akinari Sekine Japan 12 272 1.1× 129 0.6× 154 1.1× 95 1.1× 24 0.3× 113 667
Xavier Belenfant France 11 179 0.7× 121 0.6× 319 2.4× 156 1.9× 111 1.4× 27 740
Anissa Moktefi France 13 191 0.8× 109 0.5× 90 0.7× 75 0.9× 53 0.7× 46 493
Lixia Xu China 13 266 1.1× 113 0.6× 60 0.4× 40 0.5× 19 0.2× 30 464
Julie Abraham France 13 73 0.3× 233 1.2× 40 0.3× 41 0.5× 73 0.9× 32 687
Zheng Tang China 16 264 1.1× 178 0.9× 239 1.8× 185 2.2× 29 0.4× 51 796
Rossana Faedda Italy 11 180 0.7× 81 0.4× 92 0.7× 84 1.0× 33 0.4× 23 444
Döndü Üsküdar Cansu Türkiye 13 68 0.3× 166 0.8× 124 0.9× 286 3.4× 40 0.5× 86 650
S K Mak China 7 219 0.9× 33 0.2× 106 0.8× 72 0.9× 44 0.6× 12 385

Countries citing papers authored by Jonathan J. Hogan

Since Specialization
Citations

This map shows the geographic impact of Jonathan J. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Hogan more than expected).

Fields of papers citing papers by Jonathan J. Hogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Hogan. The network helps show where Jonathan J. Hogan may publish in the future.

Co-authorship network of co-authors of Jonathan J. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Hogan. A scholar is included among the top collaborators of Jonathan J. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Hogan. Jonathan J. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Baomei, Xuming Mao, Sílvio M. Vieira, et al.. (2025). Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cells. Kidney International. 109(1). 89–100. 1 indexed citations
2.
Zee, Jarcy, Jonathan J. Hogan, Ahmad Makmom Abdullah, et al.. (2024). Noninvasive Diagnostic Strategies for Membranous Nephropathy in the NEPTUNE Study. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
3.
Palmer, Matthew B., Amin Abedini, Shatakshee Chatterjee, et al.. (2021). The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort. Kidney International Reports. 6(4). 1066–1080. 21 indexed citations
4.
Bridoux, Frank, Paul Cockwell, Ilya Glezerman, et al.. (2021). Kidney injury and disease in patients with haematological malignancies. Nature Reviews Nephrology. 17(6). 386–401. 22 indexed citations
5.
Eneanya, Nwamaka D., et al.. (2021). Age and Racial Inequities in Telemedicine Internet Support Among Nephrology Outpatients During the COVID-19 Pandemic. Kidney Medicine. 3(5). 868–870. 2 indexed citations
6.
Hogan, Jonathan J., Jarcy Zee, & Laurence H. Beck. (2021). Towards optimizing use of PLA2R antibody testing in membranous nephropathy. Journal of Nephrology. 34(2). 557–559. 1 indexed citations
7.
Avasare, Rupali S., Nicole K. Andeen, Andrea Havasi, & Jonathan J. Hogan. (2021). The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era. Journal of Clinical Medicine. 10(8). 1633–1633.
8.
Uffing, Audrey, et al.. (2021). Recurrent Glomerular Disease after Kidney Transplantation. Clinical Journal of the American Society of Nephrology. 16(11). 1730–1742. 36 indexed citations
9.
Hogan, Jonathan J.. (2020). Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: Pro. Kidney360. 1(9). 887–889. 2 indexed citations
10.
Nasr, Samih H., Christophe Sirac, Frank Bridoux, et al.. (2019). Heavy Chain Fibrillary Glomerulonephritis: A Case Report. American Journal of Kidney Diseases. 74(2). 276–280. 19 indexed citations
11.
Hogan, Jonathan J., Mariam P. Alexander, & Nelson Leung. (2019). Dysproteinemia and the Kidney: Core Curriculum 2019. American Journal of Kidney Diseases. 74(6). 822–836. 38 indexed citations
12.
Cohen, Jordana B., Abdallah Sassine Geara, Jonathan J. Hogan, & Raymond R. Townsend. (2019). Hypertension in Cancer Patients and Survivors. JACC CardioOncology. 1(2). 238–251. 80 indexed citations
13.
Cohen, Jordana B., Matthew B. Palmer, Sidney Kobrin, et al.. (2018). A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney International. 94(1). 199–205. 85 indexed citations
14.
Hogan, Jonathan J.. (2018). A Case of Monoclonal Gammopathy of Renal Significance. Clinical Journal of the American Society of Nephrology. 13(6). 937–939. 1 indexed citations
15.
Sawinski, Deirdre, Jordana B. Cohen, Jayme E. Locke, et al.. (2017). Patient and Kidney Allograft Survival in Recipients With End-Stage Renal Disease From Amyloidosis. Transplantation. 102(2). 300–309. 12 indexed citations
16.
Rhodes, Joanna, et al.. (2017). Chronic Lymphocytic Leukemia and the Kidney. 1(2). 103–109. 1 indexed citations
17.
Santoriello, Dominick, Jonathan J. Hogan, & Vivette D. D’Agati. (2016). Hemophagocytic Syndrome With Histiocytic Glomerulopathy and Intraglomerular Hemophagocytosis. American Journal of Kidney Diseases. 67(6). 978–983. 19 indexed citations
18.
Hogan, Jonathan J., Glen S. Markowitz, & Jai Radhakrishnan. (2015). Drug-Induced Glomerular Disease. Clinical Journal of the American Society of Nephrology. 10(7). 1300–1310. 80 indexed citations
19.
Hogan, Jonathan J., Rupali S. Avasare, & Jai Radhakrishnan. (2014). Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 9(9). 1657–1667. 21 indexed citations
20.
Hogan, Jonathan J., Michael H. Schwenk, & Jai Radhakrishnan. (2012). Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?. Kidney International. 82(12). 1256–1260. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shikha Wadhwani Breakdown of academic impact, for papers by Akinari Sekine Breakdown of academic impact, for papers by Xavier Belenfant Breakdown of academic impact, for papers by Anissa Moktefi Breakdown of academic impact, for papers by Lixia Xu Breakdown of academic impact, for papers by Julie Abraham Breakdown of academic impact, for papers by Zheng Tang Breakdown of academic impact, for papers by Rossana Faedda Breakdown of academic impact, for papers by Döndü Üsküdar Cansu Breakdown of academic impact, for papers by S K Mak
Rankless by CCL
2026